eGain est reconnu Visionnaire dans le Magic Quadrant™ 2024 de Gartner® dans la catégorie « CRM Customer Engagement Center »
December 14, 2024 00:31 ET
|
eGain Corporation
SUNNYVALE, Californie, 14 déc. 2024 (GLOBE NEWSWIRE) -- eGain (NASDAQ : EGAN), la plateforme de gestion des connaissances alimentées par l’IA pour les services, a annoncé ce jour avoir été...
eGain reconocida como Visionaria en el Magic Quadrant™ de Gartner® de 2024 por el centro de CRM de relaciones con los clientes
December 14, 2024 00:31 ET
|
eGain Corporation
SUNNYVALE, California, Dec. 14, 2024 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), la plataforma de gestión del conocimiento de IA para el servicio al cliente, ha anunciado hoy que ha sido reconocida...
eGain è stata nominata Visionaria del Gartner® Magic Quadrant™ edizione 2024 per il CRM Customer Engagement Center
December 14, 2024 00:31 ET
|
eGain Corporation
SUNNYVALE, California, Dec. 14, 2024 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), la piattaforma di conoscenza IA per il servizio clienti, ha annunciato oggi di essere stata nominata Visionaria nel...
eGain wurde für das CRM Customer Engagement Center im Gartner® Magic Quadrant™ 2024 als Visionär bezeichnet
December 14, 2024 00:31 ET
|
eGain Corporation
SUNNYVALE, Kalifornien, Dec. 14, 2024 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), die KI-Wissensmanagement-Plattform für den Kundenservice, hat heute angekündigt, dass sie für das CRM Customer...
eGain uitgeroepen tot een Visionary voor het CRM Customer Engagement Center in het 2024 Gartner® Magic Quadrant™
December 14, 2024 00:31 ET
|
eGain Corporation
SUNNYVALE, Californië, Dec. 14, 2024 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), het AI-kennisplatform voor klantenservice, maakte vandaag bekend dat het is uitgeroepen tot Visionary voor het CRM...
Annual Changes to the Nasdaq-100 Index®
December 13, 2024 20:00 ET
|
Nasdaq, Inc.
NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective prior...
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
December 13, 2024 18:15 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food and Drug Administration (“FDA”) has approved...
Village Super Market, Inc. Declares Quarterly Dividend
December 13, 2024 17:54 ET
|
Village Super Market, Inc.
SPRINGFIELD, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Village Super Market, Inc. (NSD-VLGEA) declared quarterly cash dividends of $0.25 per Class A common share and $0.1625...
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
December 13, 2024 17:16 ET
|
NewAmsterdam Pharma N.V.
NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
Alpha Modus and Insight Acquisition Corp Close Business Combination and Alpha Modus will Begin Trading Under “AMOD” Ticker
December 13, 2024 17:10 ET
|
Alpha Modus Corp.
CORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. ("Alpha Modus" or the “Company”), a technology company with a core focus on artificial intelligence in...